55.645
0.695 (1.26%)
0.695 (1.26%)
Upgrade to Real-Time
Regular Market
| Volume | 5,371,971 |
|
|||||
| News | - | ||||||
| Day High | 55.81 | Low High |
|||||
| Day Low | 54.67 | ||||||
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Bristol Myers Squibb Co | BMY | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| 0.695 | 1.26% | 55.645 | 11:16:52 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 54.99 | 54.67 | 55.81 | 54.95 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 48,499 | 5,371,971 | $ 55.20 | $ 296,534,577 | - | 53.22 - 69.75 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 11:16:52 | 100 | $ 55.645 | USD |
Period:
Draw Mode:
Bristol Myers Squibb Co Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 123.37B | 2.22B | 2.22B | $ 42.52B | $ -5.03B | -3.99 | -22.50 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 1.84 | 3.57% | 09/30/21 | -403.06k | 0.30% |
Bristol Myers Squibb News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BMY Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 56.42 | 56.73 | 53.22 | 54.77 | 20,865,058 | -0.775 | -1.37% |
| 1 Month | 59.33 | 60.20 | 53.22 | 57.35 | 13,362,833 | -3.69 | -6.21% |
| 3 Months | 64.32 | 64.7588 | 53.22 | 58.51 | 12,223,449 | -8.67 | -13.49% |
| 6 Months | 65.24 | 69.75 | 53.22 | 62.31 | 10,249,911 | -9.59 | -14.71% |
| 1 Year | 62.43 | 69.75 | 53.22 | 62.60 | 10,831,781 | -6.79 | -10.87% |
| 3 Years | 53.58 | 69.75 | 41.19 | 56.81 | 13,267,068 | 2.07 | 3.85% |
| 5 Years | 55.69 | 70.05 | 41.19 | 56.78 | 10,909,309 | -0.045 | -0.08% |
Bristol Myers Squibb Description
| Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, oncology, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power. |
